Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ligand Pharm (LGND)

Ligand Pharm (LGND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Look for Shares of Ligand Pharm to Potentially Pullback after Yesterday's 3.02% Rise

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $101.80 to a high of $105.15. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of...

LGND : 104.71 (-0.79%)
ImmunoPrecise Strengthens Board of Directors with Antibody Business Leader, Brian Lundstrom

IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, today announced...

IPATF : 0.3775 (+9.42%)
NVO : 52.03 (+1.56%)
IPA.VN : 0.495 (+10.00%)
LGND : 104.71 (-0.79%)
Sermonix Doses First Patient in Phase 2 Clinical Trial of Lasofoxifene for Targeted Precision Medicine Treatment of Women With ESR1 Mutations in Metastatic Breast Cancer

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female-specific oncology products in the precision medicine metastatic breast cancer arena, today...

LGND : 104.71 (-0.79%)
Ligand Pharm is Among the Companies in the Biotechnology Industry with the Best Relative Performance (LGND , CCXI , ALXN , VNDA , UTHR )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ALXN : 101.34 (+2.11%)
CCXI : 7.27 (-4.22%)
LGND : 104.71 (-0.79%)
Watch for Ligand Pharm to Potentially Pullback After Gaining 4.35% Yesterday

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $96.92 to a high of $104.21. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of...

LGND : 104.71 (-0.79%)
Ligand (LGND) Surges: Stock Moves 6.3% Higher

Ligand (LGND) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

LGND : 104.71 (-0.79%)
ACOR : 2.40 (-0.41%)
Look for Shares of Ligand Pharm to Potentially Pullback after Yesterday's 8.39% Rise

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $93.36 to a high of $99.50. Yesterday, the shares gained 8.4%, which took the trading range above the 3-day high of $92.19...

LGND : 104.71 (-0.79%)
Shares of LGND Down 21.2% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 4 months, Ligand Pharm has returned 21.25% as of today's recent price of $91.80.

LGND : 104.71 (-0.79%)
Ligand Pharm Shares Down 24.8% Since SmarTrend's Sell Call (LGND)

SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 4 months, Ligand Pharm has returned 24.81% as of today's recent price of $87.65.

LGND : 104.71 (-0.79%)
After Yesterday's Decline of 3.87%, Ligand Pharm Offers Investors Better Value

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $87.39 to a high of $88.15. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $88.68...

LGND : 104.71 (-0.79%)
Why Is Ligand (LGND) Down 0.9% Since Last Earnings Report?

Ligand (LGND) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

LGND : 104.71 (-0.79%)
Ligand to Participate in the H. C. Wainwright 21st Annual Global Investment Conference

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the company is scheduled to participate in the H.C. Wainwright 21st Annual Global Investment Conference in New York City. Presentation...

LGND : 104.71 (-0.79%)
Downtrend Call Working As Ligand Pharm Stock Falls 20.7% (LGND)

SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 4 months, Ligand Pharm has returned 20.71% as of today's recent price of $92.43.

LGND : 104.71 (-0.79%)
Retrophin Down on Neurological Disorder Drug Study Failure

Retrophin (RTRX) declines as the late-stage study on a rare neurological disorder candidate failed to achieve its main goal.

BMY : 51.56 (-0.10%)
RTRX : 11.13 (-0.45%)
LGND : 104.71 (-0.79%)
ACOR : 2.40 (-0.41%)
Ligand Pharm Shares Down 19.9% Since SmarTrend's Sell Call (LGND)

SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 3 months, Ligand Pharm has returned 19.90% as of today's recent price of $93.37.

LGND : 104.71 (-0.79%)
Ligand Partner CASI Pharmaceuticals Launches EVOMELA(R) in China

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and accelerating the launch of innovative therapeutics...

LGND : 104.71 (-0.79%)
CASI : 3.15 (-1.56%)
Ligand Pharm Has Returned 21.2% Since SmarTrend Recommendation (LGND)

SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 3 months, Ligand Pharm has returned 21.15% as of today's recent price of $91.91.

LGND : 104.71 (-0.79%)
Ligand (LGND) Stock Down Despite Q2 Earnings & Sales Beat

Ligand (LGND) reports better-than-expected second-quarter 2019 results and maintains view for the full year.

NVS : 85.93 (-0.77%)
AMGN : 202.89 (+1.04%)
LGND : 104.71 (-0.79%)
CASI : 3.15 (-1.56%)
SmarTrend Watching for Potential Rebound in Shares of Ligand Pharm After 12.37% Loss

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $94.16 to a high of $102.43. Yesterday, the shares fell 12.4%, which took the trading range below the 3-day low of $105.85...

LGND : 104.71 (-0.79%)
Oversold Conditions For Ligand Pharmaceuticals (LGND)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

LGND : 104.71 (-0.79%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI -0.55 , AIZ -0.07 , SBAC -0.61 , SO -0.60 , WELL +0.61
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar